Semaglutide, the GLP-1 drug that Novo sells under the brand names Ozempic for diabetes and Wegovy for weight loss, has made ...

Rising numbers of people are needing hospital treatment for side effects from weight loss injections and it may be affecting ...

The use of weight loss drugs without doctor's supervision is not advisable and can lead to serious side effects and ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes ...

A s doctors and researchers learn more about Ozempic's health benefits, many are impressed. Besides lowering blood sugar in ...

A study reveals racial and ethnic disparities in access to Novo Nordisk's diabetes and weight loss drugs among U.S. military veterans. Black, Asian, and Native American patients are less likely to ...

New studies to be presented at the American Heart Association meeting focus on disparities in Wegovy prescriptions and ...

U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for diabetes and weight loss, according to a review of patient data published on Monday, the ...

A few different active ingredients are used to support weight loss. We’ll go over the most popular ones — semaglutide, ...

The "Today" host underwent gastric bypass surgery in 2002 to help him lose weight.

Opens in a new tab or window SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on ...